Skip to search formSkip to main contentSkip to account menu

Femarelle

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

DT56a

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Interaction between the effects of the selective estrogen modulator femarelle and a vitamin D analog in human umbilical artery vascular smooth muscle cells
2011
2011
The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women
Objective:The purpose of this study was to assess the effect of DT56a (Femarelle), a selective estrogen receptor modulator, on… 
2011
2011
"DT56a (Femarelle) Stimulates Gender-Specific Human Cultured Bone Cells In Vitro"
DT56a (Femarelle ® ) found to have SERM-like properties is used for the treatment of menopausal symptoms and osteoporosis. In… 
2009
2009
Brain-region responsiveness to DT56a (Femarelle) administration on allopregnanolone and opioid content in ovariectomized rats
Objective: The natural selective estrogen receptor modulator DT56a (Femarelle), derived from soybean, has been shown to relieve… 
2007
2007
DT56a (Femarelle): A natural selective estrogen receptor modulator (SERM)
2007
2007
Pharmacological doses of the natural phyto-SERM DT56a (Femarelle) have no effect on MCF-7 human breast cancer cell-line.
2005
2005
DT56a (Femarelle) stimulates bone formation in female rats
Objective  DT56a is a natural compound for the treatment of menopausal symptoms and osteoporosis. The aim of this study was to… 
2005
2005
"Tofupill (Femarelle ® ) Lacks Peripheral Estrogen-like Actions in the Rat Reproductive Tract"
Objective: The objective of this study was to evaluate the estrogenic effect of phytoestrogens contained in a commercial food… 
2004
2004
Efficacy and safety of standard versus low-dose Femarelle (DT56a) for the treatment of menopausal symptoms.
OBJECTIVE In a previous study treatment with a daily standard dose of Femarelle (644 mg/day) resulted in a significant elevation… 
2003
2003
DT56a (Tofupill®/Femarelle™) selectively stimulates creatine kinase specific activity in skeletal tissues of rats but not in the uterus
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)